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ABSTRACT: The respiratory system is essentially made up of a channel which starts from the nostrils and ends in 
the alveoli. Although it is  primarily  adapted for gaseous exchange, it has a resourceful defense organization which 
traverses  the nose to the alveoli. Defense structures include fine hairs, mucous membrane in the nostrils, ciliated 
epithelium in the tracheobronchial tree  and  immune cells in all parts of the respiratory tract to the alveoli. Thus in studying 
the anatomy and physiology of respiratory system ,the non-respiratory function of defense should attract adequate 
attention as partial or whole dysfunction of the respiratory tract not only has a potential capacity of compromising gaseous 
exchange but also attenuating the functional defense structures of the respiratory system. This review is thus aimed at 
bringing to lime light the defense functions of the respiratory system being one of the gateways to the entire body system. 
The review shows that the respiratory system is very versatile in its defense functions and this should be kept in view by 
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The human respiratory system is functionally 
structured for the utilization of atmospheric oxygen for 
its day to day metabolic activities and continued 
existence.  The utilization of this “currency” called 
oxygen by tissues ultimately produces CO2 which is 
expelled into the atmosphere. The atmosphere is thus 
saddled with other constituents  other than oxygen in 
such a way that each day, humans are exposed to 
varying quantity of millions of bioaerosols including 
whole organism with dentrimental effects (Prussin and 
Marr, 2015). The quantity of bioerosols that one is 
exposed to, is a function of the particular environmrnt, 
for instance in one of the few studies of concentrations 
of total bacteria and viruses in indoor air, Prussin et al. 
(2015) found virus-like and bacteria-like particle 
concentrations of ~105 and ~106 particles m-3 in 
various indoor environments and outdoor air, 
respectively. Shelton et al. (2002) measured an 
average viable airborne fungi concentration of 80 
colony-forming units (CFU) m-3 in samples collected 
from schools, hospitals, residences, and industrial 
buildings; however, in some instances concentrations 
were as high as 104 CFU m-3. To accommodate this 
atmospheric contaminants that is inevitably inspired 
the respiratory tract is encumbered with physical and 
cellular components that enables it perform defense 
functions. The review is aimed at bringing to lime light 
the defense functions of the respiratory system being 
one of the gateways to the entire body system. 
 
MATERIALS AND METHOD 
The literatures for this review where those published 
between 1962 to 2018 and they were articles from 
journals indexed in Ajol, PubMed, Medline, Embase, 
Index Medicus, Index Copernicus etc. Key words such 
as respiratory, functions, gaseous, exchange, 
immunity were used to facilitate the search for this 
review article.  
 
RESULTS AND DISCUSSION 
Defense Functions: The defense functions of the 
respiratory system include (i) passive innate response 
or functional anatomy of the respiratory system in 
relation to defense function (ii)  active innate response 
or response based on defensins, cathelicidins, alveolar 
macrophages, antimicrobial activity of surfactant/lung 
fluids (iii)  Adaptative immune response or response 
based on T and B lymphocytes 
 
Passive innate response or functional anatomy of the 
respiratory system in relation to defense function: The 
functional anatomy of the upper respiratory tract 
includes a very moist mucus membrane and an 
aerodynamic fibre complex which is made up of fine 
hairs and cilitaed epithelial cells. The fine hairs work 
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in synergy with the moist mucus membrane to trap 
foreign bodies. This action is further potentiated by the 
presence of ciliated epithelium with the cilia beating 
towards the pharynx so that foreign particles that are 
proximal to the pharynx can be swallowed. However, 
some foreign particles can be voluntarily navigated 
through the oropharynx into the mouth and 
expectorated out as mucus mixed with it (phlegm). 
This highly effective mechanism of mucocilliary 
clearance of small particles works by a complex 
interaction between cilia and mucus forming a raft on 
the top of the cilia with an appearance of  a “bunch of 
matchstick” on electron  microscopy. However, a 
number of factors may reduce mucociliary clearance 
by interfering with ciliary function or by causing 
actual ciliary damage.  A defect in the mucociliary 
clearance can be acquired through pollutants, cigarette 
smoke, anesthetic agents (local and general), bacterial 
products and viral injection. Studies have shown that 
2.46% of workers in a cement factory in Benin who 
were also chronic smokers were diagnosed of chronic 
bronchitis (Alakija et al., 1990). On the other hand, it 
can be genetic as seen Ciliopathies which are inherited 
human disorders caused by both motile and non-motile 
cilia dysfunction that form an important and rapidly 
expanding disease category ( Mitchison and Valente, 
2017).  A defect in mucociliary clearance whether 
acquired or genetic ultimately results in respiratory 
tract infections. Mucus combines with foreign 
particles that are distal to the pharynx to be blown out 
as phlegm mixed with the foreign particles.  The cough 
reflex potentiates the mucociliary clearance 
mechanism  being a protective reactive expulsion of 
plegm through the mouth after a threshold irritation of 
the gloso-pharyngeal and vagus nerves in the lower 
respiratory tract. Coughing is an important defensive 
reflex that enhances clearance of secretions and 
particulates from the airways and protects from 
aspiration of foreign materials occurring as a 
consequence of aspiration or inhalation of particulate 
matter, pathogens, accumulated secretions, postnasal 
drip, inflammation, and mediators associated with 
inflammation (Mario et al., 2012). The expression of 
phlegm from productive cough is defensive as agianst 
the non-productive cough which could be a 
complication of some medications such as angiotensin 
converting enzyme (ACE) inhibitor. The hypothetical 
pathophysiology is the inhibition of the degradation of 
protussive mediators such as bradykinin and substance 
P by Angiotensin Converting Enzyme (Dicpinigaitis, 
2006), thus these substances remain in the upper 
respiratory tract or the lungs causing persistent cough.  
This observation is consistent with the fact that 
hypertensives treated with other antihypertensive 
drugs which do not affect bradykinin metabolism is 
spared of this disturbing cough. In addition to the 
protective mucociliary mechanism  and the cough 
reflex, the nasal cavity is supplied by sensory nerve 
endings of the trigeminal nerve which is snsitive to 
irritants. The inhalation of an irriatant initiates the 
sneezing reflex. Sneezing (sternutation) is a 
coordinated protective respiratory reflex which occurs 
due to stimulation of the upper respiratory tract, 
particularly the nasal cavity (Murat and Cemal, 2009). 
A sneeze is a protective reflex expressed as the 
expulsion of air from the lungs through the mouth and 
nose  after an adequate threshold irritation of the nasal 
mucosa. Other important protective functions of 
mucus include, dilution of noxious substances, 
lubrication of the airways and humidification of 
inspired air 
 
Active innate response based on defensins, 
cathelicidins, alveolar macrophages and 
antimicrobial activity of surfactant/lung fluids: 
Defesins and Cathelicidins:  The fluids lining the 
lungs contain defensive proteins, such as complement, 
immuoglobulin, defensins, cathelicidines (powerful 
antibacterial peptides) and a variety of antiproteinases. 
Among the defensins,  the β-defensin which is widely 
expressed in the epithelial lining of the respiratory 
tract and other epithelial linings of the body is of 
utmost interest. They have a broad spectrum of 
antibacterial , antifungal and antiviral activity just like 
the peptide cathelicidin LL-37 which is also expressed 
in the epithelial cells of the respiartory tract (De Smet 
and Contreras, 2005). In addition, defensins recruit 
inflamamatory cells and promote innate and adaptive 
immune response (Tecle et al., 2010).  
 
Pulmonary Alveolar Macrophages (PAM): Alveolar 
macrophages are multipotent cells located at the 
interphase between the air and the lung tissue and 
demonstrate a formidable array of mechanisms with 
which  they recognize and phagocytose bacteria and 
other foreign particles. In addition to their first line 
phagocytic defense against microbial invasion in the 
lower respiratory tract,  they play a role in regulating 
inflammatory reaction in the lung by acting as 
chemoattractants for invading cells and stimulating 
local cells to build up proinflammatory milieu (Niesler 
et al., 2014).  Phagocytosis is categorized into opsonic 
and nonopsonic mechanisms and the pulmonary 
alveolar macrophages utilize nonopsonic, instead of 
Fc or complement receptor-mediated, phagocytosis to 
eliminate pathogens such as P. aeruginosa from the 
lung (Cheung et al., 2000). The alveolar macrophages 
exert important scavenging function in the clearance 
of dead bacteria and other cells during the after math 
of an infection and inflammation. However excessive 
or uncontrolled release of these powerful macrophage 
products may cause disordered inflammation or 
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scarring responses, which are likely to be important in 
the pathogenesis of a variety of inflammatory disease 
like asthma  
 
Antimicrobial Activity of Surfactant/Respiratory 
Fluids: Pulmonary surfactant contains four associated 
surfactant proteins (SP); SP-A, SP-B, SP-C and SP-D. 
Whereas SP-A and SP-D are hydrophilic, the SP-B 
and SP-C are highly hydrophobic (Cabre et al., 2018). 
The hydrophobic surfactant proteins are members of 
the collectins family which have in common an NH2 –
terminal collagen-like region and C-terminal lectin 
domain that binds viral and bacterial phospholipids in 
a calcium dependent manner (Crouch and Wright, 
2001; Crouch et al., 2000; Augusto et al., 2001) and 
exhibit cationic channel activity when inserted in 
planar surfactant lipid bilayer (Parra et al., 2013).  
 
The collectins play a role in innate and adaptive 
immunity (Han and Mallampalli, 2015). Studies have 
shown that SP-A and SP-D have immunomodulating 
roles in humans as well as a broad range of 
antimicrobial activity against bacteria, fungi and 
viruses (LeVine and Whitsett, 2001; McCormack and 
Whitsett, 2002). The mechanism of antimicrobial 
activity is suggested to be through the formation of 
aggregates with the pathogen to inhibit cellular 
invasion, enhance phagocytosis and alter 
inflammation such as production of reactive oxygen 
species or cytokines expression (McCormack and 
Whitsett, 2002). Also, SP-A and SP-D increases 
membrane permeability of the microbes with direct 
antibacterial activity on Escherichia coli, Klebsiella 
pneumoniae, and Enterobacter aerogenes (Wu et al., 
2003) and antifungal activity on Histoplasma 
capsulatum (McCormack et al., 2003).   
 
In humans there exist two genes, SP-A1 and SP-A2 
that encode for SP-A1 and SP-A2 proteins, 
respectively (Floros et al., 2003). This suggests a 
possibility that there may be human subpopulations 
with differential vulnerabilities to microbial infection 
based on these SP-A isoforms. More recently, it was 
found that the hydrophilic proteins SP-A and SP-D 
play a major role in host defense by inhibiting bacterial 
growth, facilitating bacterial uptake by host cells, and 
aggregating and opsonizing pathogens (Nayak et al., 
2012). The hydrophobic protein SP-B also appears to 
have some antimicrobial activity (Mulugeta and Beers, 
2006; Blanco and Pérez-Gil, 2007; Perez-Gil and 
Weaver, 2010). Mixed samples of respiratory fluid 
obtained from the nose by mechanical or chemical 
stimulation (Cole et al., 1999; Raphael et al., 1989), or 
as sputum from patients with chronic bronchitis 
(Brogan et al., 1975, Harbitz et al., 1984, Kotlar et al., 
1980) indicate that lysozyme and lactoferrin are the 
most abundant antimicrobial proteins of airway 
secretions, at approximately 0.11 mg/ml. These 
antimicrobial proteins are derived predominantly from 
serous cells of submucosal glands but also from 
surface epithelium of the respiratory tract (Dubin et 
al., 2004).   
 
Adaptative immune response or response based on T 
and B lymphocytes: Adaptive immune responses in the 
airways are mediated by B cells and T cells that 
express highly evolved and specific receptors. In some 
cases, such as autoimmune diseases or inflammatory 
diseases caused by excessive exposure to self- or 
foreign antigens, these same immune cells can cause 
disease by virtue of overly vigorous responses (Kato 
et al., 2013) . Lymphocyte are present in the various 
compartments of the respiratory tract and they play 
their role of defense against bacteria and viruses. 
Although the ratio of T helper cells to T cytotoxic cells 
varies from compartment to compartment. About 
10x109 lymphocytes have been calculated as the 
lymphocyte count for lung interstitium (mucocilliary 
epithelium  of the trachea and bronchi)  of healthy 
individuals  and a vast majority of such lymphocytes 
express CD45RO marker which is often an indictor for 
memory lymphocytes (Pabst and Tschernig, 1995; 
Upham et al., 1994 ). These lymphocytes are mainly 
T-cells with CD 8+ cytotoxic cells by far outweighing 
the CD 4+ helper cells (Pabst and Tschernig, 1995). B 
lymphoctes are hardly found in the bronchial 
epithelium;  however, 18 T lymphocytes per 100 
epithelial cells were recorded in healthy individuals 
(Fournier et al., 1989). Conversely, more T helper than 
T cytotoxic cells are found in the lamina propria and a 
considerable number of lymphocytes express surface 
immunoglobulins of about 70% T and 10% B 
lymphocytes (Hunninghake et al., 1981). One of the 
primary functions of B cells in the airways is the 
production of immunoglobulins, both within the 
parenchyma as well as for export to the mucosal 
surface of the airway (Kato et al., 2013). In particular, 
airway B cells, like those in the gut, produce polymeric 
forms of IgA and IgM that are structurally maintained 
by the joining or J chain. In humans lacking IgA, there 
is a relatively modest compromise in respiratory 
immunity because IgM production, and possibly IgD, 
is thought to compensate in the absence of IgA 
(Johansen et al., 2005).   
 
Conclusion: The respiratory tract is endowed with 
macroscopic protective structures and microscopic  
defense cells that curtail contaminants and pathogens 
coming through the open end of respiratory tract thus 
ensuring a sterile air for gaeous exchange. This should 
be kept in view by Respiratory Physicians when 
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managing respiratory conditions as this will ultimately 
brighten the overall outcome.  
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